Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity

Bibliographic Details
Title: Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
Authors: Baatz, Franziska 1, Ghosh, Arnab 2, Herbst, Jessica 1, Polten, Saskia 3, Meyer, Johann 4, Rhiel, Manuel 5, Maetzig, Tobias 4, Geffers, Robert 6, Rothe, Michael 4, Bastone, Antonella Lucia 4, John-Neek, Philipp 4, 7, Frühauf, Jörg 8, Eiz-Vesper, Britta 9, Bonifacius, Agnes 9, Falk, Christine S. 10, Kaisenberg, Constantin v. 11, Cathomen, Toni 5, 12, 13, Schambach, Axel 4, 14, van den Brink, Marcel R.M. 15, Hust, Michael 3, Sauer, Martin G. 1, ∗
Source: In Molecular Therapy 2 April 2025 33(4):1584-1607
Database: ScienceDirect
More Details
ISSN:15250016
DOI:10.1016/j.ymthe.2025.02.024
Published in:Molecular Therapy
Language:English